Provided by Tiger Fintech (Singapore) Pte. Ltd.

Travere Therapeutics, Inc.

14.91
-0.4100-2.68%
Post-market: 15.100.1900+1.27%19:25 EDT
Volume:1.13M
Turnover:16.90M
Market Cap:1.32B
PE:-5.37
High:15.51
Open:15.51
Low:14.81
Close:15.32
Loading ...
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Major Issues Report

Form 8-K - Current report
May 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Apr 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 17, 2025

Major Issues Report

Form 8-K - Current report
Feb 21, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2025

Major Issues Report

Form 8-K - Current report
Feb 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities